HIGHLIGHTS
- who: Oncotarget and collaborators from the Department of Medical Oncology, Institut Paoli-Calmettes, France have published the research: Targeted NGS array-CGH and patient-derived tumor xenografts for precision medicine in advanced breast cancer: singlecenter prospective study, in the Journal: (JOURNAL)
- what: The authors report a pilot prospective study enrolling aBC patients, in which the authors have evaluated a precision medicine-based strategy, including targeted NGS, aCGH, and PDX analyses. The aim was to prospectively determine the number of patients with actionable molecular alterations.
- how: The authors conducted a pilot study to evaluate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.